Questionnaire for Tumor-LN-oC end-usersJanuary 10, 2022
“Tumor and Lymph Node on Chip for cancer studies” (Tumor-LN-oC) is a project coordinated by the Institute of Communication and Computer Systems (ICCS) of the National Technical University of Athens and led by Professor Ioanna Zergioti who is the Principal Investigator. The consortium comprises 11 partners from Industry and Academia from 9 different EU countries.
Tumor-LN-oC aims to offer a comprehensive solution for a robust, automated tumor-lymph node-on-chip platform that will connect primary surgically removed human tumors and LN tissue from the same cancer patient. This will allow us to study the interaction of primary tumors with lymph nodes, identify their chemical signature, and offer personalized treatment relying on molecular characterization of lymph node metastasizing cells.
During the course of the project, we aim to interact both with the Regulatory Bodies and the stakeholders in order to understand the end-user requirements and to comply with the existing regulatory/legislative framework. For this reason, we have prepared a short questionnaire on end-users’ requirements and needs from an Organ-on-Chip (OoC) platform for metastasis diagnosis and drug testing.
The Tumor-LN-oC platform is targeting the monitoring of complex processes such as tissue crosstalk and metastasis and will serve as a platform for parallel preclinical testing of drugs for individual patients aiming at Precision Medicine approaches. The survey includes questions related to the operation, the analysis time, the cost and other information that in the end will co-shape the platform that will be developed during the course of the project.
If you or anyone you know would be interested in contributing, please fill out the form below and don’t hesitate to get in touch with us. Thank you for your participation!
Please find the form here: https://docs.google.com/forms/d/e/1FAIpQLSd3PKgyh5_jh-UPFGQ6QxH6uJIe-RKaGrC23DI0ncl1YFYOww/viewform